[Effect of erythromycin on peripheral neutrophil chemotaxis and experimental otitis media in rats].
Enomoto
Fuyuki
F
Kin
Takamasu
T
Kataoka
Takeshi
T
Ichikawa
Ginichiro
G
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002478:Cells, Cultured; D019743:Chemokines, CXC / Q000494:pharmacology; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004917:Erythromycin / Q000494:pharmacology* / Q000627:therapeutic use; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology; D008297:Male; D009504:Neutrophils / Q000276:immunology*; D010033:Otitis Media / Q000188:drug therapy*; D051381:Rats; D017207:Rats, Sprague-Dawley
D000900:Anti-Bacterial Agents; D019743:Chemokines, CXC; D036341:Intercellular Signaling Peptides and Proteins; D004917:Erythromycin